In this regard PLK2 can bind and phosphorylate the mutant p53, inducing an oncogenic feedback loop in cancer cells [8], or may promote Mcl-1 stabilization, thus providing resistance to cell death induced by TRAIL in Cholangiocarcinoma [9]. This evidence concerns the gene PLK2 and cancer.